Surgery combined with post-operative trancatheter arterial chemoembolization improves survival of intermediate hepatocellular carcinoma

References

• Roccarina D, Majumdar A, Thorburn D, et al. Management of people with intermediate-stage hepatocellular carcinoma: an attempted network meta-analysis. Cochrane Database Syst Rev. 2017;3:CD011649.
   PubMedGoogle Scholar
• Yi PS, Zhang M, Zhao JT, et al. Liver resection for intermediate hepatocellular carcinoma. World J Hepatol. 2016;8:607–615.
   PubMed Web of Science ®Google Scholar
• Galun D, Basaric D, Zuvela M, et al. Hepatocellular carcinoma: from clinical practice to evidence-based treatment protocols. World J Hepatol. 2015;7:2274–2291.
   PubMedGoogle Scholar
• Bruix J, Reig M, Sherman M. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology. 2016;150:835–853.
   PubMed Web of Science ®Google Scholar
• Yi PS, Zhang M, Xu MQ. Management of the middle hepatic vein in right lobe living donor liver transplantation: a meta-analysis. J Huazhong Univ Sci Technol. 2015;35:600–605.
   PubMedGoogle Scholar
• Bolondi L, Burroughs A, Dufour JF, et al. Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions. Semin Liver Dis. 2012;32:348–359.
   PubMed Web of Science ®Google Scholar
• Mazzanti R, Arena U, Tassi R. Hepatocellular carcinoma: where are we? World J Exp Med. 2016;6:21–36.
   PubMedGoogle Scholar
• Garancini M, Pinotti E, Nespoli S, et al. Hepatic resection beyond barcelona clinic liver cancer indication: when and how. World J Hepatol. 2016;8:513–519.
   PubMed Web of Science ®Google Scholar
• Ho EY, Cozen ML, Shen H, et al. Expanded use of aggressive therapies improves survival in early and intermediate hepatocellular carcinoma. HPB: Official J Int Hepato Pancreato Biliary Assoc. 2014;16:758–767.
   PubMed Web of Science ®Google Scholar
• Qi X, Liu L, Wang D, et al. Hepatic resection alone versus in combination with pre- and post-operative transarterial chemoembolization for the treatment of hepatocellular carcinoma: a systematic review and meta-analysis. Oncotarget. 2015;6:36838–36859.
   PubMed Web of Science ®Google Scholar
• Yim SY, Seo YS, Jung CH, et al. The management and prognosis of patients with hepatocellular carcinoma: what has changed in 20 years? Liver Int. 2016;36:445–453.
   PubMed Web of Science ®Google Scholar
• Pang TC, Lam VW. Surgical management of hepatocellular carcinoma. World J Hepatol. 2015;7:245–252.
   PubMed Web of Science ®Google Scholar
• Wang X, Li J, Peng Y, et al. Influence of preoperative transarterial chemoembolization on the prognosis for patients with resectable hepatocellular carcinoma: a meta-analysis of randomized trials. Hepatogastroenterology. 2011;58:869–874.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhang X, Wu L, et al. Meta-analysis: preoperative transcatheter arterial chemoembolization does not improve prognosis of patients with resectable hepatocellular carcinoma. BMC Gastroenterol. 2013;13.
   Web of Science ®Google Scholar
• Cheng X, Sun P, Hu QG, et al. Transarterial (chemo)embolization for curative resection of hepatocellular carcinoma: a systematic review and meta-analyses. J Cancer Res Clin Oncol. 2014;140:1159–1170.
   PubMed Web of Science ®Google Scholar
• Si T, Chen Y, Ma D, et al. Preoperative transarterial chemoembolization for resectable hepatocellular carcinoma in Asia area: a meta-analysis of random controlled trials. Scand J Gastroenterol. 2016;51:1512–1519.
   PubMed Web of Science ®Google Scholar
• Jianyong L, Jinjing Z, Lunan Y, et al. Preoperative adjuvant transarterial chemoembolization cannot improve the long term outcome of radical therapies for hepatocellular carcinoma. Sci Rep. 2017;7:41624.
   Web of Science ®Google Scholar
• Liao M, Zhu Z, Wang H, et al. Adjuvant transarterial chemoembolization for patients after curative resection of hepatocellular carcinoma: a meta-analysis. Scand J Gastroenterol. 2017;52:624–634.
   PubMed Web of Science ®Google Scholar
• Chen XH, Zhang BH, Yin X, et al. Effect of postoperative adjuvant transarterial chemoembolization upon early recurrence after radical resection of hepatocellular carcinoma. Zhonghua yi Xue za Zhi. 2010;90:826–829.
   PubMedGoogle Scholar
• Choi JY. Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea. Oncology. 2011;81:141–147.
   PubMed Web of Science ®Google Scholar
• Liu C, Sun L, Xu J, et al. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma. World J Surg Oncol. 2016;14:100.
   PubMed Web of Science ®Google Scholar
• Liu H, Wang ZG, Fu SY, et al. Randomized clinical trial of chemoembolization plus radiofrequency ablation versus partial hepatectomy for hepatocellular carcinoma within the Milan criteria. Br J Surg. 2016;103:348–356.
   PubMed Web of Science ®Google Scholar
• Ha TY, Hwang S, Lee YJ, et al. Absence of benefit of transcatheter arterial chemoembolization (TACE) in patients with resectable solitary hepatocellular carcinoma. World J Surg. 2016;40:1200–1210.
   PubMed Web of Science ®Google Scholar
• Xie LL, Sun CJ, Li XD, et al. Arterial embolization of massive hepatocellular carcinoma with lipiodol and gelatin sponge. Indian J Cancer. 2015;51:e49–e51.
   PubMed Web of Science ®Google Scholar
• Cheng HY, Wang X, Chen D, et al. The value and limitation of transcatheter arterial chemoembolization in preventing recurrence of resected hepatocellular carcinoma. World J Gastroenterol. 2005;11:3644–3646.
   PubMed Web of Science ®Google Scholar
• Kaibori M, Tanigawa N, Matsui Y, et al. Influence of transcatheter arterial chemoembolization on the prognosis after hepatectomy for hepatocellular carcinoma in patients with severe liver dysfunction. Anticancer Res. 2006;26:3685–3692.
   PubMed Web of Science ®Google Scholar
• Goh BK, Chow PK, Teo JY, et al. Number of nodules, Child-Pugh status, margin positivity, and microvascular invasion, but not tumor size, are prognostic factors of survival after liver resection for multifocal hepatocellular carcinoma. J Gastrointest Surg. 2014;18:1477–1485.
   PubMed Web of Science ®Google Scholar
• You DD, Kim DG, Seo CH, et al. Prognostic factors after curative resection hepatocellular carcinoma and the surgeon's role. Ann Surg Treat Res. 2017;93:252–259.
   PubMed Web of Science ®Google Scholar
• Lv T, Jiang L, Yan L, et al. Multiple tumors located in the same section are associated with better outcomes after hepatic resection for HCC patients meeting the milan criteria. J Gastrointest Surg. 2015;19:2207–2214.
   PubMed Web of Science ®Google Scholar
• Sun JJ, Wang K, Zhang CZ, et al. Postoperative adjuvant transcatheter arterial chemoembolization after R0 hepatectomy improves outcomes of patients who have hepatocellular carcinoma with microvascular invasion. Ann Surg Oncol. 2016;23:1344–1351.
   PubMed Web of Science ®Google Scholar
• Ye JZ, Zhang YQ, Ye HH, et al. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus. World J Gastroenterol. 2014;20:17141–17147.
   PubMed Web of Science ®Google Scholar